156 related articles for article (PubMed ID: 17179945)
21. Species differences in the effects of prostanoids on MAP kinase phosphorylation, myosin light chain phosphorylation and contraction in bovine and cat iris sphincter smooth muscle.
Kaddour-Djebbar I; Ansari HR; Akhtar RA; Abdel-Latif AA
Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):49-57. PubMed ID: 15589399
[TBL] [Abstract][Full Text] [Related]
22. A historical perspective and recent advances in prostamide research and therapeutics.
Burk RM; Woodward DF
Curr Opin Drug Discov Devel; 2007 Jul; 10(4):413-21. PubMed ID: 17659482
[TBL] [Abstract][Full Text] [Related]
23. Bimatoprost-induced calcium signaling in human T-cells does not involve prostanoid FP or TP receptors.
Chen J; Lu RT; Lai R; Dinh T; Paul D; Venadas S; Wheeler LA
Curr Eye Res; 2009 Mar; 34(3):184-95. PubMed ID: 19274525
[TBL] [Abstract][Full Text] [Related]
24. Intestinal effects of isoprostanes: evidence for the involvement of prostanoid EP and TP receptors.
Elmhurst JL; Betti PA; Rangachari PK
J Pharmacol Exp Ther; 1997 Sep; 282(3):1198-205. PubMed ID: 9316826
[TBL] [Abstract][Full Text] [Related]
25. Characterization of the prostanoid receptor(s) on human blood monocytes at which prostaglandin E2 inhibits lipopolysaccharide-induced tumour necrosis factor-alpha generation.
Meja KK; Barnes PJ; Giembycz MA
Br J Pharmacol; 1997 Sep; 122(1):149-57. PubMed ID: 9298541
[TBL] [Abstract][Full Text] [Related]
26. Effects of isoprostanes and prostanoids on porcine small intestine.
Unmack MA; Rangachari PK; Skadhauge E
J Pharmacol Exp Ther; 2001 Feb; 296(2):434-41. PubMed ID: 11160628
[TBL] [Abstract][Full Text] [Related]
27. Identification and pharmacological characterization of the prostaglandin FP receptor and FP receptor variant complexes.
Liang Y; Woodward DF; Guzman VM; Li C; Scott DF; Wang JW; Wheeler LA; Garst ME; Landsverk K; Sachs G; Krauss AH; Cornell C; Martos J; Pettit S; Fliri H
Br J Pharmacol; 2008 Jul; 154(5):1079-93. PubMed ID: 18587449
[TBL] [Abstract][Full Text] [Related]
28. Pharmacological characterization of thromboxane and prostanoid receptors in human isolated urinary bladder.
Palea S; Toson G; Pietra C; Trist DG; Artibani W; Romano O; Corsi M
Br J Pharmacol; 1998 Jul; 124(5):865-72. PubMed ID: 9692770
[TBL] [Abstract][Full Text] [Related]
29. Anandamide-derived prostamide F2α negatively regulates adipogenesis.
Silvestri C; Martella A; Poloso NJ; Piscitelli F; Capasso R; Izzo A; Woodward DF; Di Marzo V
J Biol Chem; 2013 Aug; 288(32):23307-21. PubMed ID: 23801328
[TBL] [Abstract][Full Text] [Related]
30. Molecular pharmacology of the DP/EP2 class prostaglandin AL-6598 and quantitative autoradiographic visualization of DP and EP2 receptor sites in human eyes.
Sharif NA; Williams GW; Crider JY; Xu SX; Davis TL
J Ocul Pharmacol Ther; 2004 Dec; 20(6):489-508. PubMed ID: 15684809
[TBL] [Abstract][Full Text] [Related]
31. Replacement of the carboxylic acid group of prostaglandin f(2alpha) with a hydroxyl or methoxy substituent provides biologically unique compounds.
Woodward DF; Krauss AH; Chen J; Gil DW; Kedzie KM; Protzman CE; Shi L; Chen R; Krauss HA; Bogardus A; Dinh HT; Wheeler LA; Andrews SW; Burk RM; Gac T; Roof MB; Garst ME; Kaplan LJ; Sachs G; Pierce KL; Regan JW; Ross RA; Chan MF
Br J Pharmacol; 2000 Aug; 130(8):1933-43. PubMed ID: 10952685
[TBL] [Abstract][Full Text] [Related]
32. Prostanoid EP(1)- and TP-receptors involved in the contraction of human pulmonary veins.
Walch L; de Montpreville V; Brink C; Norel X
Br J Pharmacol; 2001 Dec; 134(8):1671-8. PubMed ID: 11739243
[TBL] [Abstract][Full Text] [Related]
33. Multitargeting of selected prostanoid receptors provides agents with enhanced anti-inflammatory activity in macrophages.
Wang JW; Woodward DF; Martos JL; Cornell CL; Carling RW; Kingsley PJ; Marnett LJ
FASEB J; 2016 Jan; 30(1):394-404. PubMed ID: 26420849
[TBL] [Abstract][Full Text] [Related]
34. Effects of prostaglandin E2, F2alpha, and latanoprost acid on isolated ocular blood vessels in vitro.
Astin M
J Ocul Pharmacol Ther; 1998 Apr; 14(2):119-28. PubMed ID: 9572537
[TBL] [Abstract][Full Text] [Related]
35. Generation second messengers by prostanoids in the iris-sphincter and ciliary muscles of cows, cats and humans.
Bhattacherjee P; Smithson M; Paterson CA
Prostaglandins Leukot Essent Fatty Acids; 1997 Jun; 56(6):443-9. PubMed ID: 9223655
[TBL] [Abstract][Full Text] [Related]
36. Agonist activity of bimatoprost, travoprost, latanoprost, unoprostone isopropyl ester and other prostaglandin analogs at the cloned human ciliary body FP prostaglandin receptor.
Sharif NA; Kelly CR; Crider JY
J Ocul Pharmacol Ther; 2002 Aug; 18(4):313-24. PubMed ID: 12222762
[TBL] [Abstract][Full Text] [Related]
37. Real-time intracellular Ca2+ mobilization by travoprost acid, bimatoprost, unoprostone, and other analogs via endogenous mouse, rat, and cloned human FP prostaglandin receptors.
Kelly CR; Williams GW; Sharif NA
J Pharmacol Exp Ther; 2003 Jan; 304(1):238-45. PubMed ID: 12490597
[TBL] [Abstract][Full Text] [Related]
38. New fluoroprostaglandin F(2alpha) derivatives with prostanoid FP-receptor agonistic activity as potent ocular-hypotensive agents.
Nakajima T; Matsugi T; Goto W; Kageyama M; Mori N; Matsumura Y; Hara H
Biol Pharm Bull; 2003 Dec; 26(12):1691-5. PubMed ID: 14646172
[TBL] [Abstract][Full Text] [Related]
39. Possible involvement of brain prostaglandin E2 and prostanoid EP3 receptors in prostaglandin E2 glycerol ester-induced activation of central sympathetic outflow in the rat.
Shimizu T; Tanaka K; Nakamura K; Taniuchi K; Yawata T; Higashi Y; Ueba T; Dimitriadis F; Shimizu S; Yokotani K; Saito M
Neuropharmacology; 2014 Jul; 82():19-27. PubMed ID: 24657150
[TBL] [Abstract][Full Text] [Related]
40. Prostaglandin E2 suppression of acetylcholine release from parasympathetic nerves innervating guinea-pig trachea by interacting with prostanoid receptors of the EP3-subtype.
Spicuzza L; Giembycz MA; Barnes PJ; Belvisi MG
Br J Pharmacol; 1998 Mar; 123(6):1246-52. PubMed ID: 9559911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
